BMO raises Abbvie stock price target to $300 on Skyrizi strength
BMO raises Abbvie stock price target to $300 on Skyrizi strength
BMO raises Abbvie stock price target to $300 on Skyrizi strength
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.